Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Pharmaceuticals 2010, 3(2), 379-392; doi:10.3390/ph3020379
Review

Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain

 and *
Received: 18 December 2008; in revised form: 20 January 2010 / Accepted: 28 January 2010 / Published: 3 February 2010
(This article belongs to the Special Issue Cell-penetrating Peptides)
View Full-Text   |   Download PDF [175 KB, uploaded 3 February 2010]
Abstract: The inability of most drugs to cross the blood-brain barrier and/or plasma membrane limits their use for biomedical applications in the brain. Cell Permeable Peptides (CPPs) overcome this problem and are effective in vivo, crossing the plasma membrane and the blood-brain barrier. CPPs deliver a wide variety of compounds intracellularly in an active form. In fact, many bioactive cargoes have neuroprotective properties, and due to their ability to block protein-protein interactions, offer exciting perspectives in the clinical setting. In this review we give an overview of the Cell Permeable Peptides strategy to deliver neuroprotectants against neurodegeneration in the CNS.
Keywords: CPPs; neuroprotection; protein-protein interaction; drug discovery; brain CPPs; neuroprotection; protein-protein interaction; drug discovery; brain
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Antoniou, X.; Borsello, T. Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain. Pharmaceuticals 2010, 3, 379-392.

AMA Style

Antoniou X, Borsello T. Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain. Pharmaceuticals. 2010; 3(2):379-392.

Chicago/Turabian Style

Antoniou, Xanthi; Borsello, Tiziana. 2010. "Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain." Pharmaceuticals 3, no. 2: 379-392.


Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert